Global peptide therapeutics market 2014 2018

During his tenure at Inovio, Dr. Dhillon led the successful turnaround of the company through a restructuring, acquisition of technology from several European and North American companies, and a merger with VGX Pharmaceuticals to develop a vertically integrated DNA vaccine development company with one of the strongest development pipelines in the industry.

Global peptide therapeutics market 2014 2018

Biocon's first product to go to market was papainan enzyme found in papaya which is used to prevent beer from turning hazy. Inthe Irish Biocon was acquired by Unilever.

Pardon Our Interruption

In the mids, Kiran Mazumdar—Shaw decided to focus on biopharmaceuticals rather than enzymes. But Unilever, a major shareholder, did not want to be in the biopharmaceuticals business. Biocon becomes an independent entity. She founded Biocon in She has received two Indian national awards— Padma Shri and Padma Bhushan for her pioneering efforts in Industrial Biotechnology.

Shaw received a graduate honours degree in Zoology from Bangalore University and qualified as a Master Brewer from Ballarat UniversityAustralia She received an honorary Doctorate of Science in from Ballarat University in recognition of her contributions to biotechnology.

Microbiome R&D and Business Collaboration Forum: USA

Shaw set up the Biocon Foundation in To me corporate social responsibility is getting that balance right that you got to make sure that you invest in the community that supports your business. Experience of more than 47 years in the field of Finance.

Subsidiaries, Acquisitions and Strategic Global Alliances[ edit ] Syngene International Pvt Ltd[ edit ] Established inSyngene International Limited is Biocon's custom research organisation offering pharmaceutical and biotechnology majors customised solutions in synthetic chemistry and molecular biology for early-stage drug discovery and development.

It offers high-value services from target identification and validation to small molecule and library synthesis, on a strong platform of confidentiality and intellectual property protection. Recently it has collaborated with Abbott Nutrition.

AxiCorp also won the German AOK a leading public health insurer tender for Metformin, marking an important milestone for Biocon's entry into the generics market as well as enabling it to market biosimilar insulin and analogues in the German market. AxiCorp is now an autonomous subsidiary of Biocon and the most successful Indian owned German pharmaceutical company.

It is a It also launched Abraxane in the UAE. Amylin provides expertise in peptide hormone development, particularly in the area of phybrid technology and metabolic disease therapeutics.

Biocon will utilise its expertise in recombinant microbial expression and experience in preclinical and clinical development of diabetes products to manufacture the compound.

The companies are co-developing candidate products based upon IATRICa's technology platform and Biocon's expertise in drug development, biologics manufacturing, and clinical research.

Global peptide therapeutics market 2014 2018

The goal of this collaboration is to develop a therapeutic vaccine where the T cell mediated immunity is enhanced and maintained against a tumor which otherwise evades immune responses. Methods of developing, characterising and scaling up of conjugated monoclonal antibody production are being currently studied.

Global peptide therapeutics market 2014 2018

Mylan and Biocon will share development, capital and other costs to bring products to market. The partnership was initiated in Biocon's strategic partnership with Vaccinex allows access to their proprietary human antibody platform technology, thereby providing a strong IP protection to Biocon's antibody pipeline.

Biocon receives an upfront licensing fee and, following approval in the licensed territories, royalties from Abraxis BioScience. The partnership has also helped Biocon's Oncotherapeutics division add another frontline anti-cancer drug—Abraxane—to its portfolio. In-licensed from Abraxis BioScience, Biocon has obtained the rights to market Abraxane in India for the treatment of breast cancer.

Under the terms of the agreement, both companies will share responsibility for end-to-end development, manufacturing and global regulatory approvals for a number of products, and will have a cost and profit share arrangement globally.What is World Orphan Drug Congress? World Orphan Drug Congress is Europe's meeting place for the rare disease community.

The Conference offers strategic keynote plenaries, themed tracks and dedicated networking sessions, you have the chance to really . Thank you for registering for the SLAS Europe Conference and Exhibition, we look forward to seeing you in Brussels on June, Peptides are recognized for being highly selective and efficacious and, at the same time, relatively safe and well tolerated.

Consequently, there is an increased interest in peptides in pharmaceutical research and development (R&D), and approximately peptide therapeutics are .

Search reports

Global Peptide Therapeutics Market 1. TechNavio Insights Global Peptide Therapeutics Market 2. Market Overview: Peptide Therapeutics About Peptide Therapeutics • Peptides are amino acids sequences and among the most potent biologically active substances found in nature. Type or paste a DOI name into the text box.

Click Go. Your browser will take you to a Web page (URL) associated with that DOI name. Send questions or comments to doi. Peptide Therapeutics Market to be driven by the rising prevalence of cancer worldwide and also the rise in research activities and development pipeline of peptide drugs The global market for peptide therapeutics has been witnessing a substantial rise in its size and valuation since the last few years.

Growth, Trends, and Forecast Location: State Tower, 90 State Street, Suite , Albany,

World Orphan Drug Congress | 12 - 14 November